Thursday, 1 October 2026
Equity key to reducing cancer care costs for employers
Diet Links

Equity key to reducing cancer care costs for employers

Equity is key to reducing cancer care costs for employers, according to Karen van Caulil of the Florida…

By Calloway Fairfax  •  19/09/2026
Alcohol Abuse Tops Trauma-Related Heart Risk
Diet Links

Alcohol Abuse Tops Trauma-Related Heart Risk

Alcohol abuse surpasses trauma as a key predictor of heart risk in a study of 219,866 Danish adults.

By Calloway Fairfax  •  18/09/2026
Shingles Vaccine May Reduce Heart Disease Risk
Diet Links

Shingles Vaccine May Reduce Heart Disease Risk

A 2026 study finds the shingles vaccine may lower heart disease risk over a seven‑year period, giving seniors…

By Calloway Fairfax  •  08/09/2026
AI systems could soon act without human oversight
Diet Links

AI systems could soon act without human oversight

AI systems operating without human oversight raise legal and ethical questions—who’s responsible when autonomous tech fails?

By Calloway Fairfax  •  07/09/2026
Murray Discusses ACA Marketplace Shifts and Nonnetwork Plans
Diet Links

Murray Discusses ACA Marketplace Shifts and Nonnetwork Plans

ACA marketplace changes threaten premium tax credits, pushing enrollees toward high‑deductible bronze plans that may cost thousands more…

By Lyra Ashworth  •  31/08/2026
Margaret Murray Critiques Republicans on Medicaid Stance
Diet Links

Margaret Murray Critiques Republicans on Medicaid Stance

Margaret Murray critiques Republicans on Medicaid stance, calling the overhaul's provisions, including work requirements and redetermination cycles, deeply…

By Ember Pennington  •  30/08/2026
6 Signs You May Benefit from Facial Rejuvenation
Diet Links

6 Signs You May Benefit from Facial Rejuvenation

Most people considering facial rejuvenation describe the same vague feeling: something looks different, but they cannot say exactly…

By Calloway Fairfax  •  27/08/2026
FDA approves new drug for rare bone disease
Diet Links

FDA approves new drug for rare bone disease

The FDA approves Pasatru, a breakthrough drug for fibrodysplasia ossificans progressiva (FOP), a rare bone disease affecting 900…

By Ember Pennington  •  24/08/2026
Sparsentan Access Guidance for Kidney Disease Patients
Diet Links

Sparsentan Access Guidance for Kidney Disease Patients

Sparsentan access guidance for kidney disease patients with evidence-based coverage criteria and clinical judgment.

By Calloway Fairfax  •  23/08/2026
California’s generic insulin struggles to gain traction
Diet Links

California’s generic insulin struggles to gain traction

California’s generic insulin program, CalRx, offers affordable insulin at $55 but faces slow adoption despite lower costs. Learn…

By Lyra Ashworth  •  18/08/2026